Literature DB >> 14576407

Cancer. A risky business--assessing breast cancer risk.

Ephrat Levy-Lahad1, Sharon E Plon.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14576407     DOI： 10.1126/science.1091465

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  BRCA1/2 population screening: embracing the benefits.

Authors:  S E Plon
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677

Review 2.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

3.  Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.

Authors:  Marcelo Carvalho; Maria A Pino; Rachel Karchin; Jennifer Beddor; Martha Godinho-Netto; Rafael D Mesquita; Renato S Rodarte; Danielle C Vaz; Viviane A Monteiro; Siranoush Manoukian; Mara Colombo; Carla B Ripamonti; Richard Rosenquist; Graeme Suthers; Ake Borg; Paolo Radice; Scott A Grist; Alvaro N A Monteiro; Blase Billack
Journal:  Mutat Res       Date:  2008-10-17       Impact factor: 2.433

4.  A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.

Authors:  Eliseos J Mucaki; Natasha G Caminsky; Ami M Perri; Ruipeng Lu; Alain Laederach; Matthew Halvorsen; Joan H M Knoll; Peter K Rogan
Journal:  BMC Med Genomics       Date:  2016-04-11       Impact factor: 3.063
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.